These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease. Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758 [TBL] [Abstract][Full Text] [Related]
64. Campaign to control genetic blood diseases in Bahrain. Al Arrayed S Community Genet; 2005; 8(1):52-5. PubMed ID: 15767757 [TBL] [Abstract][Full Text] [Related]
65. A pilot beta-thalassaemia screening program in the Albanian population for a health planning program. Baghernajad-Salehi L; D'Apice MR; Babameto-Laku A; Biancolella M; Mitre A; Russo S; Di Daniele N; Sangiuolo F; Mokini V; Novelli G Acta Haematol; 2009; 121(4):234-8. PubMed ID: 19556751 [TBL] [Abstract][Full Text] [Related]
66. Prevalence of sickle cell disease among Grenadian newborns. Antoine M; Lee K; Donald T; Belfon Y; Drigo A; Polson S; Martin F; Mitchell G; Etienne-Julan M; Hardy-Dessources MD J Med Screen; 2018 Mar; 25(1):49-50. PubMed ID: 29183229 [TBL] [Abstract][Full Text] [Related]
67. [Neonatal screening for sickle cell anemia in metropolitan France. For the group for neonatal screening of sickle cell anemia of the French Association for Screening and Prevention of Infant Handicaps (AFDPHE)]. Galactéros F Pathol Biol (Paris); 1999 Jan; 47(1):13-8. PubMed ID: 10081774 [TBL] [Abstract][Full Text] [Related]
68. Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation. Núñez-Jurado D; Payán-Pernía S; Álvarez-Ríos AI; Jiménez-Jambrina M; Concepcion Pérez-De-Soto I; José Palma-Vallellano A; Zapata-Bautista R; Carlos Hernández-Castellet J; Paz Garrastazul-Sánchez M; Arqueros-Martínez V; Urbano-Ramos MDM; Abdelkader-Maanan M; Raúl García-Lozano J; Delgado-Pecellín C Am J Perinatol; 2024 May; 41(S 01):e893-e900. PubMed ID: 36580977 [TBL] [Abstract][Full Text] [Related]
69. Neonatal screening for sickle haemoglobinopathies in Birmingham. Griffiths KD; Raine DN; Mann JR Br Med J (Clin Res Ed); 1982 Mar; 284(6320):933-5. PubMed ID: 6802355 [TBL] [Abstract][Full Text] [Related]
70. Sickle cell disease in North Europe. Howard J; Davies SC Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983 [TBL] [Abstract][Full Text] [Related]
71. Cardiorenal risk prevalence in sickle cell hemoglobinopathy. Abo-Zenah H; Moharram M; El Nahas AM Nephron Clin Pract; 2009; 112(2):c98-c106. PubMed ID: 19390209 [TBL] [Abstract][Full Text] [Related]
72. Sickle cell disease: time for a targeted neonatal screening programme. Gibbons C; Geoghegan R; Conroy H; Lippacott S; O'Brien D; Lynam P; Langabeer L; Cotter M; Smith O; McMahon C Ir Med J; 2015 Feb; 108(2):43-5. PubMed ID: 25803954 [TBL] [Abstract][Full Text] [Related]
74. Estimated incidence of sickle-cell disease in Aruba and St. Maarten suggests cost-effectiveness of a universal screening programme for St. Maarten. van Heyningen AM; Levenston MJ; Tamminga N; Scoop-Martijn EG; Wever RM; Verhagen AA; van der Dijs FP; Dijck-Brouwer DA; Offriinga PJ; Muskiet FA West Indian Med J; 2009 Sep; 58(4):301-4. PubMed ID: 20099768 [TBL] [Abstract][Full Text] [Related]
75. Prevalence of beta-thalassaemia and sickle cell traits in premarital screening in Al-Qassim, Saudi Arabia. El-Tayeb EN; Yaqoob M; Abdur-Rahim K; Gustavson KH Genet Couns; 2008; 19(2):211-8. PubMed ID: 18618996 [TBL] [Abstract][Full Text] [Related]
76. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios. Allaf B; Patin F; Elion J; Couque N Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571 [TBL] [Abstract][Full Text] [Related]
77. Neonatal screening of sickle cell anemia: a preliminary report. Panigrahi S; Patra PK; Khodiar PK Indian J Pediatr; 2012 Jun; 79(6):747-50. PubMed ID: 22278214 [TBL] [Abstract][Full Text] [Related]
78. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease. Dexter D; McGann PT Br J Haematol; 2022 Jan; 196(1):63-69. PubMed ID: 34340260 [TBL] [Abstract][Full Text] [Related]
80. MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC. El Osta M; Benoist JF; Naubourg P; Bonacorsi S; Messine R; Ducoroy P; Allaf B Clin Chem Lab Med; 2024 May; 62(6):1149-1157. PubMed ID: 38353144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]